137 related articles for article (PubMed ID: 33530259)
1. Low PRRX1 expression and high ZEB1 expression are significantly correlated with epithelial-mesenchymal transition and tumor angiogenesis in non-small cell lung cancer.
Yang R; Liu Y; Wang Y; Wang X; Ci H; Song C; Wu S
Medicine (Baltimore); 2021 Jan; 100(4):e24472. PubMed ID: 33530259
[TBL] [Abstract][Full Text] [Related]
2. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
3. Immunohistochemical analysis of the expression of E-cadherin and ZEB1 in non-small cell lung cancer.
Matsubara D; Kishaba Y; Yoshimoto T; Sakuma Y; Sakatani T; Tamura T; Endo S; Sugiyama Y; Murakami Y; Niki T
Pathol Int; 2014 Nov; 64(11):560-8. PubMed ID: 25347933
[TBL] [Abstract][Full Text] [Related]
4. ZEB1-responsive genes in non-small cell lung cancer.
Gemmill RM; Roche J; Potiron VA; Nasarre P; Mitas M; Coldren CD; Helfrich BA; Garrett-Mayer E; Bunn PA; Drabkin HA
Cancer Lett; 2011 Jan; 300(1):66-78. PubMed ID: 20980099
[TBL] [Abstract][Full Text] [Related]
5. Activation of histamine H4 receptors decreases epithelial-to-mesenchymal transition progress by inhibiting transforming growth factor-β1 signalling pathway in non-small cell lung cancer.
Cai WK; Hu J; Li T; Meng JR; Ma X; Yin SJ; Zhao CH; He GH; Xu GL
Eur J Cancer; 2014 Apr; 50(6):1195-206. PubMed ID: 24447834
[TBL] [Abstract][Full Text] [Related]
6. PRRX1 promotes lymph node metastasis of gastric cancer by regulating epithelial-mesenchymal transition.
Yao J; Zhang Y; Xia Y; Zhu C; Wen X; Liu T; Da M
Medicine (Baltimore); 2021 Feb; 100(6):e24674. PubMed ID: 33578599
[TBL] [Abstract][Full Text] [Related]
7. ZEB1 promotes the progression and metastasis of cervical squamous cell carcinoma via the promotion of epithelial-mesenchymal transition.
Ma Y; Zheng X; Zhou J; Zhang Y; Chen K
Int J Clin Exp Pathol; 2015; 8(9):11258-67. PubMed ID: 26617850
[TBL] [Abstract][Full Text] [Related]
8. PRRX1 deficiency induces mesenchymal-epithelial transition through PITX2/miR-200-dependent SLUG/CTNNB1 regulation in hepatocellular carcinoma.
Chen W; Wu J; Shi W; Zhang G; Chen X; Ji A; Wang Z; Wu J; Jiang C
Cancer Sci; 2021 Jun; 112(6):2158-2172. PubMed ID: 33587761
[TBL] [Abstract][Full Text] [Related]
9. Relationship of E-cadherin, Beta-catenin, N-cadherin, ZEB1 and αSMA as Epithelial Mesenchymal Transition markers with prognostic factors in early and advanced stage laryngeal squamous cell carcinomas.
Kucuk U; Ekmekci S; Talu CK; Pekcevik Y; Cukurova I
Indian J Pathol Microbiol; 2023; 66(2):237-245. PubMed ID: 37077062
[TBL] [Abstract][Full Text] [Related]
10. Correlations of the ZEB1 expression with the incidence and prognosis of non-small cell lung cancer.
Ma DJ; Liu HS; Li SQ; Qin YZ; He J; Li L; Cui YS
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1528-1535. PubMed ID: 30840275
[TBL] [Abstract][Full Text] [Related]
11. Expression of epithelial-mesenchymal transition-related markers in triple-negative breast cancer: ZEB1 as a potential biomarker for poor clinical outcome.
Jang MH; Kim HJ; Kim EJ; Chung YR; Park SY
Hum Pathol; 2015 Sep; 46(9):1267-74. PubMed ID: 26170011
[TBL] [Abstract][Full Text] [Related]
12. The role of epithelial mesenchymal transition markers in thyroid carcinoma progression.
Montemayor-Garcia C; Hardin H; Guo Z; Larrain C; Buehler D; Asioli S; Chen H; Lloyd RV
Endocr Pathol; 2013 Dec; 24(4):206-12. PubMed ID: 24126800
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of ZEB1, a master epithelial-to-mesenchymal transition (EMT) gene, suppresses anchorage-independent cell growth of lung cancer cells.
Takeyama Y; Sato M; Horio M; Hase T; Yoshida K; Yokoyama T; Nakashima H; Hashimoto N; Sekido Y; Gazdar AF; Minna JD; Kondo M; Hasegawa Y
Cancer Lett; 2010 Oct; 296(2):216-24. PubMed ID: 20452118
[TBL] [Abstract][Full Text] [Related]
14. ZEB1 Mediates Acquired Resistance to the Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer.
Yoshida T; Song L; Bai Y; Kinose F; Li J; Ohaegbulam KC; Muñoz-Antonia T; Qu X; Eschrich S; Uramoto H; Tanaka F; Nasarre P; Gemmill RM; Roche J; Drabkin HA; Haura EB
PLoS One; 2016; 11(1):e0147344. PubMed ID: 26789630
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological significance of ZEB1 protein in patients with hepatocellular carcinoma.
Zhou YM; Cao L; Li B; Zhang RX; Sui CJ; Yin ZF; Yang JM
Ann Surg Oncol; 2012 May; 19(5):1700-6. PubMed ID: 21584833
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological significance of SOX4 and epithelial-mesenchymal transition markers in patients with laryngeal squamous cell carcinoma.
Zhang M; Li H; Han Y; Wang M; Zhang J; Ma S
Auris Nasus Larynx; 2021 Dec; 48(6):1167-1175. PubMed ID: 34001394
[TBL] [Abstract][Full Text] [Related]
17. PARP-1 induces EMT in non-small cell lung carcinoma cells via modulating the transcription factors Smad4, p65 and ZEB1.
Kumar M; Jaiswal RK; Prasad R; Yadav SS; Kumar A; Yadava PK; Singh RP
Life Sci; 2021 Mar; 269():118994. PubMed ID: 33417952
[TBL] [Abstract][Full Text] [Related]
18. Roles of STAT3 and ZEB1 proteins in E-cadherin down-regulation and human colorectal cancer epithelial-mesenchymal transition.
Xiong H; Hong J; Du W; Lin YW; Ren LL; Wang YC; Su WY; Wang JL; Cui Y; Wang ZH; Fang JY
J Biol Chem; 2012 Feb; 287(8):5819-32. PubMed ID: 22205702
[TBL] [Abstract][Full Text] [Related]
19. Expression of miR-9 and miR-200c, ZEB1, ZEB2 and E-cadherin in Non-Small Cell Lung Cancers in Iran.
Nourmohammadi B; Tafsiri E; Rahimi A; Nourmohammadi Z; Daneshvar Kakhaki A; Cho W; Karimipoor M
Asian Pac J Cancer Prev; 2019 Jun; 20(6):1633-1639. PubMed ID: 31244281
[TBL] [Abstract][Full Text] [Related]
20. Transcription factors related to epithelial mesenchymal transition in tumor center and margin in invasive lung adenocarcinoma.
Maeng YI; Kim KH; Kim JY; Lee SJ; Sung WJ; Lee CK; Park JB; Park KK
Int J Clin Exp Pathol; 2014; 7(7):4095-103. PubMed ID: 25120788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
